首页> 外文期刊>Pharmaceutical statistics. >Simultaneous confidence interval for assessing non-inferiority with assay sensitivity in a three-arm trial with binary endpoints
【24h】

Simultaneous confidence interval for assessing non-inferiority with assay sensitivity in a three-arm trial with binary endpoints

机译:与二元终点三臂试验中的测定敏感度评估非劣升性的同时置信区间

获取原文
获取原文并翻译 | 示例
       

摘要

A three-arm trial including an experimental treatment, an active reference treatment and a placebo is often used to assess the non-inferiority (NI) with assay sensitivity of an experimental treatment. Various hypothesis-test-based approaches via a fraction or pre-specified margin have been proposed to assess the NI with assay sensitivity in a three-arm trial. There is little work done on confidence interval in a three-arm trial. This paper develops a hybrid approach to construct simultaneous confidence interval for assessing NI and assay sensitivity in a three-arm trial. For comparison, we present normal-approximation-based and bootstrap-resampling-based simultaneous confidence intervals. Simulation studies evidence that the hybrid approach with the Wilson score statistic performs better than other approaches in terms of empirical coverage probability and mesial-non-coverage probability. An example is used to illustrate the proposed approaches.
机译:包括实验治疗、积极参考治疗和安慰剂在内的三组试验通常用于评估实验治疗的非劣效性(NI)和分析敏感性。在一项三组试验中,已经提出了通过分数或预先指定的裕度来评估NI检测灵敏度的各种基于假设检验的方法。在三臂试验中,关于置信区间的研究很少。本文提出了一种混合方法,用于在三组试验中同时构建评估NI和分析灵敏度的置信区间。为了进行比较,我们提出了基于正态近似和基于bootstrap重采样的同时置信区间。仿真研究表明,结合威尔逊评分统计的混合方法在经验覆盖概率和近中非覆盖概率方面优于其他方法。通过一个例子说明了所提出的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号